With Novo Nordisk Dependent On GLP-1s, Even Perceived Price Pressures Can Hurt

 
• By Sten Stovall
Price
Novo Nordisk foresees basal insulin prices being squeezed further in 2019 • Source: Shutterstock

More from Business

More from Scrip